Notice2024-25989
Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 8, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Drug Overdose Surveillance and Epidemiology (DOSE). This data collection is designed to facilitate rapid identification and tracking of Emergency Department (ED) data on eight drug overdose indicators.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 217 (Friday, November 8, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 217 (Friday, November 8, 2024)]
[Notices]
[Pages 88774-88776]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-25989]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-25-1268; Docket No. CDC-2024-0093]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a continuing information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled Drug Overdose Surveillance and Epidemiology (DOSE). This data
collection is designed to facilitate rapid identification and tracking
of Emergency Department (ED) data on eight drug overdose indicators.
DATES: CDC must receive written comments on or before January 7, 2025.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0093 by either of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">www.regulations.gov</a>. Follow
the instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to <a href="http://www.regulations.gov">www.regulations.gov</a>.
Please note: Submit all comments through the Federal eRulemaking
portal (<a href="http://www.regulations.gov">www.regulations.gov</a>) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: <a href="/cdn-cgi/l/email-protection#4926242b092a2d2a672e263f"><span class="__cf_email__" data-cfemail="335c5e51735057501d545c45">[email protected]</span></a>.
[[Page 88775]]
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Drug Overdose Surveillance and Epidemiology (DOSE) (OMB Control No.
0920-1268, Exp. 9/30/2025)--Revision--National Center for Injury
Prevention and Control (NCIPC), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
In 2022, a total of 107,941 drug overdose deaths occurred,
corresponding to an age-adjusted rate of 32.6 per 100,000 population,
quadruple from the 2002 rate (8.2). From 2021 to 2022, the synthetic
opioid-involved death rate other than methadone increased 4.1%, from
21.8 to 22.7 per 100,000. The psychostimulant-involved age-adjusted
death rate increased more than 34 times, from 0.3 in 2002 to 10.4 in
2022, and two states had a significant increase in non-fatal overdoses
between 2023 and 2024. In response to the growing severity of the
opioid overdose epidemic, the US government declared the opioid
overdose epidemic a public health emergency (PHE) on October 26, 2017.
The opioid overdose epidemic is one of the U.S. Department of Health
and Human Services (HHS) top priorities. In 2021, HHS expanded their
Overdose Prevention Strategy to focus on four strategic priorities:
primary prevention, harm reduction, evidence-based treatment, and
recovery support.
Drug Overdose Surveillance and Epidemiology (DOSE) 2.0 is made
possible because the vast majority of the participating health
departments are already rapidly collecting extensive data on Emergency
Department (ED) visits in their jurisdiction and using these data for
the identification of public health concerns including flu and other
respiratory illnesses, heat-related illness, and hurricane-related
health issues. DOSE 1.0 ensured participating jurisdictions use their
data to track suspected overdoses by providing participating
jurisdictions standardized definitions of ED visits involving all drug,
all opioid, heroin and all stimulant overdoses. To further advance
overdose surveillance, for DOSE 2.0, CDC added four additional drug
indicators--fentanyl, cocaine, methamphetamine, and benzodiazepine.
This facilitates rapid identification and tracking of ED data on a
total of eight drug overdose indicators.
Also, no single ED surveillance system has national coverage, but
almost all participating health departments use one of three systems--
the NSSP BioSense System, local ED syndromic surveillance, or ED/
inpatient hospital discharge overdose data files. DOSE 2.0 integrates
data across these three types of ED surveillance to quickly build a
national surveillance system while leveraging existing ED data
collection efforts. DOSE 2.0 can use data across the three types of ED
surveillance systems because the key data requirement is the ability to
detect change over time (e.g., data consistently collected within the
jurisdiction overtime) and not comparability across participating
health departments (e.g., same data collection methods deployed across
state health departments overtime).
CDC is requesting OMB approval for three years with an annual
estimated burden of 655 hours. There is no cost to respondents other
than their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average Total
Number of Responses burden per annual
Type of respondent Form name respondents per response burden
respondent (hours) (hours)
----------------------------------------------------------------------------------------------------------------
Participating health departments Rapid ED overdose data 45 12 0.5 270
sharing aggregate data from NSSP form.
BioSense.
Participating health departments Rapid ED overdose data 3 12 3 108
sharing aggregate data from local form.
syndromic data file.
Participating health department ED and hospitalization 32 1 3 96
sharing finalized ED and inpatient discharge overdose
hospitalization aggregate data on data form.
total ED/inpatient hospitalization
visits, and metadata on a yearly
basis.
Participating health department Inpatient 3 1 2 6
sharing finalized aggregate data on hospitalization
total inpatient hospitalization discharge overdose
visits, and metadata on a yearly data form.
basis.
Participating health department ....................... 35 1 5 175
sharing line-level ED/inpatient
hospitalization discharge data
(.csv) on drug overdose-related
visits (i.e., any visit with an ICD-
10-CM code between T36-T50,
including all intents, encounters,
underdosing, and adverse effects.
-------------------------------------------------
[[Page 88776]]
Total............................ ....................... ........... ........... ........... 655
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-25989 Filed 11-7-24; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on November 8, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.